74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Omnicell Inc
Closed
Sector Healthcare
39.68 0.05
Overview
Share price change
24h
Min
39.48
Max
39.77
Income | 7.2M 16M |
|---|---|
Sales | 25M 307M |
P/E Sector Avg | 148.593 73.394 |
EPS | 0.6 |
Profit margin | 5.162 |
EBITDA | -15M 12M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +41.49 upside |
Next Earnings | 1 May 2025 |
|---|
Market Cap | -207M 1.9B |
|---|---|
Previous open | 39.63 |
Previous close | 39.68 |
News Sentiment
By Acuity
17%
83%
19 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Omnicell Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Omnicell Inc Forecast
Price Target
By TipRanks
41.49% upside
12 Months Forecast
Average 56.2 USD 41.49%
High 69 USD
Low 40 USD
Based on 6 Wall Street analysts offering 12 month price targets forOmnicell Inc - Dist in the last 3 months.
Sentiment
By Acuity
19 / 393 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Omnicell Inc
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. Its point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility’s in-house information management systems. Its Central Pharmacy IV Compounding Service offers a comprehensive service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.
